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Abstract. Intravenous (i.v.) injection of mice with lipopolysaccharide (LPS), and the 
proteolytic enzymes trypsin and proteinase, mobilizes pluripotent haemopoietic stem 
cells (CFU-s) as well as granulocyte-macrophage progenitor cells (GM-CFU) and the 
early progenitors of the erythroid lineage (E-BFU) from the haemopoietic tissues into 
the peripheral blood. We investigated the involvement of the complement (C) system 
in this process. It appeared that the early mobilization induced by LPS and other 
activators of the alternative complement pathway, such as Listeria rnonocytogenes 
(Lm) and zymosan, but not that induced by the proteolytic enzymes, was absent in 
CS-deficient mice. The mobilization by C activators in these mice could be restored by 
injection of CS-sufficient serum, suggesting a critical role for CS. 
The manner in which C5 was involved in the C activation-mediated stem cell 
mobilization was studied using a serum transfer system. CS-sufficient serum, activated 
in vitro by incubation with Lm and subsequently liberated from the bacteria, caused 
mobilization in both CS-sufficient and CS-deficient mice. CS-deficient serum was not 
able to do so. The resistance of the mobilizing principle to heat treatment ( 5 6 O C ,  
30 min) strongly suggests that it is identical with the C5 split product CSa, or an in 
v i m  derivative of CSa. This conclusion was reinforced by the observation that a single 
injection of purified rat C5a into CS-deficient mice also induced mobilization of 
CFU-s. 
Haemopoietic stem cells (CFU’s), granulocyte-macrophage progenitor cells (GM-CFU) and 
the early progenitor cells of erythrocytes (E-BFU) occur in the peripheral blood in extremely 
low numbers (Goodman & Hodgson, 1962; Hara & Ogawa, 1977; Rickard et al., 1971). 
Their frequency in the blood can be increased by intravenous (i.v.) injection of certain 
substances which stimulate their mobilization out of the haemopoietic tissues into the blood 
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stream. These substances include lipopolysaccharides (LPS), zymosan, proteolytic enzymes, 
polyanions and lectins (Vos, Buurman & Ploemacher, 1972; Quesenberry et al., 1973; Ross 
et al., 1976; van der Ham, Benner & Vos, 1977; Cline & Golde, 1977; Vos & Wilschut, 
1979). 
In mice, depending on the agent injected, peak CFU-s numbers are found 10 min to 6 hr 
after injection. LPS and zymosan, in addition, cause a ‘delayed’ accumulation of CFU-s and 
haemopoietic progenitor cells in the peripheral blood and spleen, reaching peak numbers 
about 5 days after injection of the agent (Vos et a1.,1972; Staber & Johnson, 1980; Benner et 
al., 198 1 : Molendijk, Ploemacher & Erkens-Versluis, 1982). Early CFU-s mobilization by 
LPS, zymosan and proteolytic enzymes, but not by polyanions, can be prevented by prior 
decomplementation with the complement (C) activating factor of cobra venom (CoF) 
(Wilschut et al.. 1979). LPS and zymosan are also incapable of early mobilization of CFU-s 
in complement C5-deficient mice (Benner et al., 1981). The delayed CFU-s accumulation in 
blood and spleen by these agents, on the other hand, was not affected in CS-deficient mice. 
The experiments described in this paper were designed to explore the role of the C system 
in the early mobilization of CFU-s and haemopoietic progenitor cells by LPS and proteolytic 
enzymes in more detail. The results suggest that C5a is the active principle in the LPS-induced 
mobilization of CFU-s and haemopoietic progenitor cells. C5a did not appear to be required 
for mobilization of the various types of colony-forming cells by proteolytic enzymes. 
M A T E R I A L S  A N D  M E T H O D S  
Mice and rats 
Male and female mice of the following strains were used: AKR (CS-deficient), DBA/2 
(C5-deficient), (C3H/Law x DBA/2)F 1 (CS-sufficient), B 10. D2/oSn (C5-deficient), 
B10. DZ/nSn (CS-sufficient) and (C57BL/Rij x CBA/Rij)Fl (CS-sufficient). The AKR, 
DBA/2 and (C3H/Law x DBA/2)F1 mice were purchased from the Radiobiological Institute 
TNO, Rijswijk, The Netherlands, B 10. D2/oSn mice from Jackson Laboratories, Bar Harbor, 
Maine, U.S.A., B 10. DZ/nSn mice from Bantin and Kingman, Aldbrough, U.K., and 
(C57BL/Rij x CBA/Rij)FI mice from the Laboratory Animals Center of the Erasmus 
University, Rotterdam. The Netherlands. For the spleen colony assay male mice were used. 
The age of all donor and recipient mice ranged between 12 and 24 weeks. Lewis rats, 
8-12 weeks old, were purchased from the Central Institute for the Breeding of Laboratory 
Animals TNO, Zeist. The Netherlands. 
Mobilizing agents 
LPS from Salrnottella abortus equi was kindly provided by Dr C. Galanos, Max-Planck 
Institut fur Immunobiologie. Freiburg, F.R.G. The properties and source of the proteinase and 
trypsin used were described previously (Vos et al., 1972; van der Ham et a/., 1977; Vos & 
Wilschut. 1979: Wilschut ef al., 1979). Mobilizing agents were dissolved in pyrogen-free 
phosphate buffered saline (PBS). They were injected i.v. in a volume of 0.5 ml PBS. 
Cell suspensions 
After killing the mice by exposure to carbon dioxide, blood samples were collected by cardiac 
puncture and immediately heparinized in plastic tubes containing preservative-free lithium 
heparin (Sigma. Detroit, Michigan. U.S.A.). 
For cell culture. one volume of heparinized blood was mixed with one volume of 0.2% 
methylcellulose in a-median (a-modification of Dulbecco minimal essential medium). Red 
blood cells were allowed to sediment for 30 min at room temperature. The leucocyte-rich 
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plasma was pipetted off and the cells were washed twice in a-medium containing 2% fetal calf 
serum (FCS). 
Cell culture 
Aliquots of 5 x lo5 or lo6 nucleated blood cells were cultured in 35 x 10 mm plastic tissue 
culture dishes at 37°C in a fully humidified incubator in an atmosphere of 5% CO, in air. The 
culture medium consisted of a-medium supplemented with 0.8% methylcellulose, 1 % 
de-ionized bovine serum albumin (No A-9647; Sigma, St. Louis, Missouri, U.S.A.), 10% 
FCS, M 2-mercaptoethanol (Merck-Schuchardt, Hohenbrunn, F.R.G.), 20% mouse 
spleen Con A conditioned medium and 2.0 U of sheep plasma erythropoietin (Connaught 
Laboratories Ltd., Willowdale, Ontario, Canada). Granulocyte/macrophage colonies, 
containing at least 50 cells, were counted on day 7 of culture, erythroid bursts on day 10. 
All cultures were done in triplicate. 
Irradiation 
Whole body irradiation was performed with a 13’Cs (Gammacell 40, Atomic Energy of 
Canada Ltd., Ottawa, Canada) at a dose rate of 1-29 Gy/min. (C57BL/Rij x CBA/Rij)Fl 
mice received 9 Gy, AKR and (C57BL/6J x DBA/2)F1 mice 8.5 Gy. 
Spleen colony assay 
The spleen colony assay of Till & McCulloch (196 1) was performed as described previously 
(Molendijk et al., 1982). The spleens were taken out 8 days after irradiation and i.v. injection 
of the blood samples. 
Complement activation in vitro 
For the in oitro activation of C, mouse or rat serum was used from non-heparinized blood that 
was allowed to clot for 90 rnin at room temperature. One ml of serum was mixed with 0.5 ml 
of saline containing 3.2 x lo9 heat-inactivated (56O; 60 min) L. monocytogenes bacteria. This 
mixture was incubated for 30 min at 37°C. After incubation the bacteria were pelleted by 
centrifugation at 5000 r.p.m. for 10 min at 4OC. The remaining bacteria were removed from 
the supernatant by filtration through a 0-22 p m  filter (Millipore, Bedford, Massachusetts, 
U.S.A.). Control serum from the same bleeding was mixed with saline only, but otherwise 
similarly treated. 
Heat inactivation of complement 
Mouse serum was heat-decomplemented by incubation in a waterbath for 30 min at 56OC. 
Assay for alternative complement pathway activity 
The alternative complement pathway activity of the serum samples activated by 
L. monocytogenes bacteria was determined as described previously (van Dijk, Rademaker & 
Willers, 1980; van Kessel et al., 1981). 
Purification of rat C5a 
One hundred and seventy five ml of fresh rat plasma collected in 2 mM-EDTA, 1 unit/ml of 
trasylol, 2 mM benzamidine and 0.5 mM fluryl-methyl-sulphonyl fluoride (PMSF) was 
precipitated with a final concentration of 6% polyethyleneglycol-6000 during 60 min at 0°C. 
After centrifugation (15 min, 5000 g) the precipitate was dissolved in 35 ml Tris-HCI buffer 
(0.01 M Trizma base, containing the above mentioned inhibitors and adjusted to a PH of 7 . 8  
with HCl) dialyzed overnight at 4OC against the same buffer, and applied on a 1.5 x 45 cm 
DEAE Sephacel column which was equilibrated in dialysis buffer. After collection of 
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50 fractions of 5 ml each, bound C5  was eluted using a linear salt gradient. The C5  haemolytic 
activity (Daha et al., 1982), which was eluted from the column with a conductivity between 
6 and 8 mS, was pooled, dialyzed against 0 . 0 1 ~  acetate buffer, pH 6 .3  and subjected to 
cation-exchange chromatography of a 1.5 x 20 cm Sulphopropyl-C5O column. C5 
haemolytic activity, eluted from the column with a linear salt gradient and found between 
3 and 5 mS, was concentrated to a volume of 5 ml and subjected to gelfiltration on a 
2 . 5  x 90 cm Sephacryl S300 column. C 5  haemolytic activity which filtered with an apparent 
molecular weight of 185,000 daltons was pooled and applied on a column of Sepharose 4B to 
which anti-rat-C3 and anti-rat-H were coupled (Daha et al., 1979; Daha & van Es, 1982) to 
remove minor contaminants of rat-C3 and rat-H from the C5 preparation. The final C5  
preparation was homogeneous on SDS-PAGE analysis. 
To obtain C5a, 3 mg purified C5 an isotonic Verona1 buffered saline was reacted during 
60 min at 37°C with 1 x lo9 intermediates bearing the classical pathway C5  convertase 
EAC1423 (Daha, Hazevoet & Van Es, 1983). The intermediates were then removed by 
centrifugation and the small molecular weight C5a was obtained by gelfiltration on 
Sephadex-G75. The final material was dialysed against distilled H,O, freeze-dried and finally 
resuspended in 2 ml pyrogen-free 0.15 M NaCI. 
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R E S U L T S  
Mobilization of CFU-s, GM-CFU and E-BFU in C5-deficient mice by LPS 
Complement C5-deficient mice. e.g. DBA/2, B 10. DZ/oSn and AKR (Cinader, Dubiski & 
Wardlaw, 1964; Rosen, 1975), are incapable of CFU-s mobilization upon i.v. injection of LPS 
(Benner et al., 1981). We investigated whether the mobilization of GM-CFU and E-BFU is 
similarly defective in CS-deficient mice. Therefore, C5-deficient DBA/2, B 10. D2/oSn and 
AKR mice and genetically related, C5-sufficient (C3H x DBA/2)F1 mice and BlO.D2/nSn 
mice were injected with LPS or PBS. In the control mice, injection of LPS led to the 
mobilization of CFU-s as well as GM-CFU and E-BFU (Table 1). The increase in GM-CFU 
and E-BFU numbers was proportionally smaller than that of CFU-s. In the CS-deficient mice, 
mobilization of all three cell types was weak or absent (Table 1). The data from the 
C5-sufficient and C5-deficient mouse strains differ significantly (P < 0.0001). 
Mobilization of CFU-s in C5-deficient mice by proteolytic enzymes 
Injection of C5-deficient mice with the proteolytic enzymes trypsin and proteinase did induce 
mobilization of CFU-s into the peripheral blood. Both enzymes were found to cause a dose 
dependent increase of blood CFU-s numbers in normal as well as C5-deficient mice (Table 2). 
Mobilization of CFU-s in C5-deficient mice injected with C5-sufficient serum 
Injection of C5-deficient DBA/2 mice with 1 ml serum from C5-sufficient (C57BL x CBA)Fl 
mice enabled these DBA/2 mice to respond to injection of LPS with CFU-s mobilization. 
DBA/2 mice, injected with 300 pg LPS i.v. 1 hr after infusion of the C5-sufficient serum, had 
306 ? 100 CFU-s/ml blood at 30 min after LPS injection, whereas control DBA/2 mice 
injected with the same amount of LPS had 64 k 19 CFU-s/ml blood. 
CFU-s mobilization by serum-containing activated complement 
The fact that LPS is an activator of the alternative C pathway, and the observation that 
LPS-induced CFU-s mobilization is absent in decomplemented and C5-deficient mice, suggest 
that activation of C5  via the alternative C pathway may be important for the LPS-induced 
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Table 1. Mobilization of CFU-s, GM-CFU and E-BFU by LPS in the C5-deficient mouse strains DBA/2, 
BlO.D2/oSn and AKR 
CFU-s/ml blood* 
Mouse strain C5 t  PBS LPS 
GM-CFU/ml blood E-BFU/ml blood 
PBS LPS PBS LPS 
DBA/2 - 4 2 f 4 $  7 2 f 4  
(C3H x DBA/2)Fl + 16 f 3 730 f 61 
21 f 6  1OOOf88 
B lO.DZ/oSn - 4 4 & 5  72 & 10 
40 f 7 
B lO.DZ/nSn + 48 f 5  7 6 0 1 9 2  
5 1  + 5  5 9 4 f 4 5  
AKR - 5 2 f 7  21 2 7  
29 f 4 80 f 4 
92 f 5 
43 f 5 
86 f 9  664 f 39 
5 O f  3 532 f 2 8  
78 f 9 42 f 13 
23 f 2 1 8 f 2  
7 5 f  9 259 f 1 
11Ok 19 779 I 2 9  
14 k 5 1 7 f 3  
18 k 8 12 f 5 
80 f 6 
~~ ~ ~ 
20 f 2 19 f 4  
104 I 13 284 2 15 
1 3 k 2  93 f 7 
14 f 6 14 f 3 
24 f 5 61 f 6  
9 f 4  8 f 2  
20 f 4 16 f 6 
* Blood was taken 30 min after i.v. injection of 300 pg LPS or 0.5 ml PBS. 
t C5-sufficient mouse strains are indicated by +, C5-deficient mouse strains by -. 
Arithmetic mean f SEM. 
Table 2. CFU-s mobilization by trypsin and proteinase in the C5-deficient mouse strains DBA/2, BlO.DZ/oSn 
and AKR 
C FU-s/ml blood * 
0.4 mg 2.0 rng 0.1 mg 0.5 mg 
Mouse strain c 5 t  PBS trypsin trypsin proteinase proteinase 
~ ~~ 
DBA/2 - 46 f 8 119 f 9 367 f 97 150 k 44 640 f 65 
52 1 1 1  7 1 + 9  loo k 7 319 f 20 594 t 43 
(C3H x DBA/2)FI + 45 1 7  89 t 48 240 f 112 209 +_ 38 570 f 65 
1 6 f 3  45 * 12 160 f 32 404 f 15 547 f 58 
B lO.DZ/oSn - 37 f 9 3 0 +  8 143 f 52 8 1 f 8  381 k 37 
40 t 7 91 11 160 f 21 216 5 18 405 f 22 
B 1O.D2/nSn + 53 f 6 81 f 11 90 f 29 186 f 9 440 t 40 
48 f 5 97 f 6 180 f 16 187 13 400 t 32 
AKR - 52 f 7 61 f 6  106 14 150 22 586 & 74 
29 f 4  142 f 8 180 f 16 300 f 18 686 t 78 
* Blood was taken 30 min after i.v. injection of trypsin, proteinase or PBS. 
t C5-sufficient mouse strains are indicated by +, C5-deficient mouse strains by -. 
$ Arithmetic mean I SEM. 
CFU-s mobilization. To investigate this putative mediatory role of C, normal mouse serum 
(NMS) was incubated in vitro with Listeria monocytogenes (Lm) which has also been shown 
to activate C via the alternative pathway (Van Kessel et al., 1981). C activation was measured 
by determining the remaining alternative pathway C activity (van Dijk et al., 1980). Figure 1 
shows that in vitro incubation of (C57BL x CBA)FI serum with Lm led to a complete C 
consumption as determined in the haemolytic assay. Neither before nor after incubation with 
Lm did the serum of C5-deficient mice show haemolytic activity. 
Injection of mice with Lm-treated serum from CS-sufficient mice was found to cause a 4- 
to 7-fold increase in the blood CFU-s numbers within 30 min (Table 3). Serum which had 
been heat-inactivated (30 min 56OC) to destroy the C enzymes and subsequently incubated 
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Fig. I .  Haemolytic complement activity of normal (C57BL x CBA)FI (0) and DBA/2 (0) serum, and 
Lm-acthated (C57BL x CBA)Fl  (W) and DBA/2 (0) serum. 
Table 3. CFU-s mobilization by Lisreria-treated normal mouse serum 
~~ 
CFU-siml blood* 
Serum donor C 5 t  Recipient C 5 t  N M S j  Lm NMS INACT-Lm-NMS 
~~~~~~ 
(C57BL Y CBA)FI + (C57BL x CBA)FI + 87 k 5 §  
26 k 7 
DBAi2 ~ (C57BL x CBA)FI + 73 k 8 
5 9 i 4  
AKR - ( C 5 7 B L x  CBA)FI + 55 f 7 
78 f 6 
(C57BL x CBA)Fl  + DBA/2 - 149 f I0 
I05 f I 1  
326 f 13 85 & 9 
304 k 22 46 k 6 
92 ? 7 92 & 4 
61 k 6  
56 6 19 & 6 
90 ? 5 160 2 6 
669 f 22 128 4 
695 i 48 118 & 9 
* Blood was taken 30 min after i.v. injection of 0 .75  ml serum. 
t C5-sufficient mouse strains are indicated by +. C5-deficient mouse strains by -. 
I NMS means normal mouse serum; Lm-NMS means NMS incubated with Lisreria bacteria: INACT-Lm- 
NMS means NMS from which the complement enzymes were inactivated by treatment for 30 min at 56°C and 
was subsequently incubated with Lisreria bacteria. 
8 Arithmetic mean & SEM. 
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with Lm had no significant activity. Lm-treated serum from C5-deficient DBA/2 and A K R  
mice could not cause an increase in the blood CFU-s numbers. 
Since the observed CFU-s mobilization in C5-sufficient mice injected with Lm-treated 
NMS might be due to activation of the recipients C system, we also injected C5-deficient 
DBA-2 mice with Lm-treated C5-sufficient (C57BL x CBA)Fl serum. Also under these 
conditions, Lm-treated serum caused CFU-s mobilization (Table 3). The somewhat increased 
numbers of CFU-s in the peripheral blood of the NMS-infused control mice are at  the upper 
limit of the normal range found in untreated control mice. As to the normal variation in 
background circulating CFU-s numbers, in each experiment a control group was included 
from the same supplier and delivery. 
Not only Lm-activated NMS mobilized CFU-s, but also Lm-activated normal rat serum 
was able to do  so. This is shown in Table 4 for Lewis rat serum infused in C5-deficient DBA/2 
mice. 
CSa, in contrast to most other C components, including native C5, is resistent to 
heat-inactivation for 30 min at 56°C (Hugli & Muller-Eberhard, 1978). We made use of this 
property to determine whether C5a may be the intermediate in the LPS-induced mobilization 
of CFU-s. Indeed, NMS from C5-sufficient mice that had been incubated with Lm, and 
subsequently heat-inactivated, was still able to mobilize CFU-s. This was found in 
C5-sufficient (C57BL x CBA)FI recipients as well as in C5-deficient DBA/2 recipients 
(Table 5) .  
Table 4. CFU-s mobilization by Listeriu-treated rat serum 
CFU-s/ml blood* 
Serum donor C 5 t  Recipient mice C S t  PBS NRaS$ Lm-NRaS 
Lewis rat + DBA/2 - 27 f 65 2.5 + 6  270 f 48 
~~ ~~ ~ ~ ~~ 
* Blood samples were taken 30 min after i.v. injection of 0.75 ml serum. 
t Lewis rats are CS-suflicient, DBA/2 mice are CS-deficient. 
$ NRaS means normal rat serum; Lm-NRaS means NRaS that has been incubated with Listeria bacteria. 
5 Arithmetic mean f SEM. 
Table 5. CFU-s mobilization by heat inactivated Listeriu-treated normal mouse serum 
CFU-s/MI blood* 
Serum donor c 5 1  Recipient C 5 t  NMSS Lm-NMS Lm-NMS-INACT 
(C57BL x CBA)FI + (C57BL x CBA)Fl + 86 f 75 495 + 2 1  333 f 17 
124 f 8  686 f 2 8  630 f 20 
(C57BL x CBA)Fl + DBA/2 - 2 4 f 7  146f  18 172 f 35 
172 & 38 23 f 5  191 k 3 8  
21 k 14 3 6 8 f 3 8  225 f 74 
* Blood samples were taken 30 min after i.v. injection of 0.75 ml serum. 
t CS-sufficient mouse strains are indicated by +, C5-deficient mouse strains by -. 
$ NMS means normal mouse serum; Lm-NMS means NMS incubated with Lisferiu bacteria: Lm-NMS- 
INACT means NMS that was incubated with Listeria bacteria and was subsequently treated for 30 min at 56OC 
to inactivate the complement enzymes, except CSa. 
0 Arithmetic mean +_ SEM. 
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CFU-s mobilization by purified rat C5a 
The possible mediatory role of C5a in murine CFU-s mobilization was further analysed by 
infusing C5-deficient DBA/2 mice with purified rat C5a. Rat C5a was used because no 
isolation procedures are available for mouse C5a, as yet. It was found that purified rat C5a 
caused a dose-dependent accumulation of CFU-s in the peripheral blood (data not shown). 
After i.v. injection of 25 p g  purified rat CSa, maximum numbers of circulating CFU-s were 
found after 15 to 30 min (Table 6) .  The peak numbers of CFU-s induced by purified rat C5a 
were of the same order of magnitude as those caused by injection of C5-sufficient mice with 
LPS or by injection of Lm-activated NMS or Lm-activated normal rat serum (c.f. Tables 1, 3 
and 4). 
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Table 6. CFU-s mobilization in C5-deficient DBA/2 mice injected with purified rat C5a 
Min after injection of purified rat C5a* 
PBS 5 15 30 60 I20 
61 & I l l ’  160 & 32 323 2 60 240 3 56 218 & 53 95 & 15 
26 -t 4 6 8 t  17 222 k 39 399 t 113 230 k 38 52 & 8 
P valuel P = 0.030 P = 0.0024 P z 0 . 0 1 4  P = 0.01 1 P = 0.035 
Blood samples were taken at the indicated intervals after i.v. injection of 25 pug purified rat C5a. 
t Figures represent the arithmetic mean & 1 SEM of the number of CFU-s per ml blood. 
$ P-values (calculated by the two-sided Student r-test) refer to comparison of the figures found at the various 
intervals after injection of rat C5a and the figures obtained after injection of PBS. 
D I S C U S S I O N  
A variety of studies show that i.v. injection of mice with bacterial LPS induces the 
mobilization of CFU-s from the haemopoietic tissues into the peripheral blood within minutes 
of injection (Vos et al., 1972; Vos & Wilschut, 1979). This early mobilization is not restricted 
to CFU-s since more mature cell types are also mobilized, although not all to the same extent 
(Ploemacher et af., 1980). The present studies extend these observations by showing that 
GM-CFU and E-BFU are also rapidly mobilized by LPS. It can thus be concluded that the 
early LPS-induced mobilization of haemopoietic cells neither has cell-type specificity nor is 
restricted to particular differentiation stages. 
In a previous paper we have concluded that the C system is involved in the early 
LPS-induced mobilization of C FU-s, since LPS-induced C FU-s mobilization is deficient in 
mice that have been pre-treated with CoF (Wilschut ef al., 1979) and also in C5-deficient mice 
(Benner et al., 1981). In the present paper it appears that this role of the C system is not 
restricted to the mobilization of CFU-s. The mobilization of GM-CFU, E-BFU (Table 1) and 
mature cell types (data not shown) is also highly defective in C5-deficient mice. This suggests 
that C is involved in the LPS-induced mobilization of all types of haemopoietic cells. 
In the LPS-non-responder mouse strains C3H/HeJ and C57BL/lO.ScCr, which lack a 
serologically identifiable structure (‘LPS-receptor’) that is present in all LPS-responder strains 
(Forni & Coutinho, 1978), the late but not the early mobilization of CFU-s upon LPS 
injection is absent (Benner et al., 1981). Together with the above data concerning the role of 
C, this observation suggests that not the LPS-receptor, but one or more C components may 
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be the active principle(s) which account for the rapid mobilization of haemopoietic cells after 
LPS injection. 
In the present paper we show that in vitro activation of C5-sufficient NMS and normal rat 
serum by Lm leads to the formation of product(s) that can induce CFU-s mobilization in 
C5-deficient mice (Table 3 and 4). Such Lm-activated serum is still active after 
heat-inactivation for 30 min at 56°C (Table 3). As C5a and its nonspecific helper factor, in 
contrast to most other C components, are resistant to heat inactivation (Hugli & 
Miiller-Eberhard, 1978; Perez & Goldstein, 1981), this observation suggests that C5a or an in 
vivo derivative of C5a is the active principle in the LPS-induced early mobilization of CFU-s 
and haemopoietic progenitor cells. This might be related to the chemotactic activity of C5a 
(Snyderman et al., 1969; Fernandez et al., 1978), supposing that CFU-s and haemopoietic 
progenitor cells have a binding site for this fragment. 
Recent data suggest that spleen colonies measured at 7-8 days after i.v. injection of 
CFU-s and colonies measured on days 12-13 are derived from (partly) different 
subpopulations of CFU-s (Bertoncello, Hodgson & Bradley, 1985). As we determined the 
spleen colonies on day 8 only, the data presented refer to this particular subpopulation only. It 
would be of interest to investigate whether CFU-s that give rise to days 12-13 colonies behave 
similarly. 
The mechanism of translation of such a chemotactic stimulus is not entirely known. When 
the active substance reaches the surface of the cell, an esterase is activated and the 
hexosemonophosphate shunt is stimulated. Subsequently, calcium enters the cytoplasm and 
the cytoplasmic contractile proteins assemble (Loor, 1980). Thus, both the energy and the 
means required for the movement of the cell are provided. 
Alternatively, the haemopoietic cells might be sent passively into the circulation, being 
brought about by other cells which are known to be susceptible to the chemotactic activity of 
C5a, such as neutrophils and macrophages (Snyderman et al., 1969; Snyderman, Shin & 
Hauseman, 1971). Furthermore, it cannot be excluded that the mobilization by C5a is 
mediated by its property to induce contraction of smooth muscle, or the fact that it is an 
anaphylatoxin inducing the release of histamine from mast cells and basophils (Hugli & 
Miiller-Eberhard, 1978), which may lead to increased vascular permeability. 
It is remarkable that the mobilization of CFU-s and haemopoietic progenitor cells by 
trypsin and proteinase is not decreased in C5-deficient mice, since previous studies have 
shown that decomplementation of mice by high doses of CoF does inhibit CFU-s mobilization 
by these enzymes (Wilschut et al., 1979). Proteolytic enzymes, however, have been shown to 
activate C3 directly (Bokisch, Miiller-Eberhard & Cocchrane, 1969; Molenaar et al., 1974), 
so that the effects of these enzymes on CFU-s mobilization in C5-deficient mice are most 
likely to be explained by C3-activation and, consequently, release of C3a, which is also an 
anaphylatoxin, but which has only limited chemotactic activity (Snyderman et al., 1969; 
Hugli & Miiller-Eberhard, 1978). The inability of CoF-treated mice to respond to trypsin and 
proteinase is probably due to exhaustion of C3 (as well as later components of the C 
cascade), so that CoF-treated mice cannot generate C3a and C5a, and thus cannot mobilize 
CFU-S. 
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